EverHint – Breakout Ultra Tight – Top 6 Signals for Jul 07, 2026

What This Signal Is

High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.

Entry Criteria:

• Strong RSI momentum (configurable thresholds)
• Volume surge above average
• Price momentum confirmation
• Minimum ADV: $25M+ (varies by variant)
• Earnings buffer: 7 days pre/post earnings
• Variant-specific filters applied

Holding period: 1-4 weeks | Risk level: Medium-High

Market Context

Equity markets are experiencing a modest but broad-based pullback, with the Nasdaq's 1.20% decline outpacing the Dow's more measured 0.25% drop — a pattern that suggests investors are rotating away from growth and technology-heavy positions toward more defensive areas. This divergence is meaningful for momentum swing strategies, as it signals a short-term softening in risk appetite rather than a full trend reversal. Traders should remain selective, favoring setups with clear directional conviction over speculative momentum plays.

The VIX rising 4.11% to 16.21 is worth monitoring closely. While this level remains within historically moderate territory, the intraday acceleration in volatility can expand bid-ask spreads and increase the likelihood of stop-outs on tighter swing positions. For momentum-based signals, this environment can cut both ways — elevated intraday swings create opportunity but also demand disciplined position sizing and wider tolerance for short-term noise.

Healthcare emerging as the top sector for today's signals aligns well with the current risk-off tone. Healthcare tends to attract capital during periods of uncertainty due to its defensive characteristics, and sector rotation data here supports that thesis. Momentum swing strategies in defensive sectors like Healthcare may carry a higher probability of follow-through in this environment, as institutional rotation can provide a sustained tailwind that pure momentum alone cannot guarantee.

📊 Signals (6 of 6 total)

Ranked by composite momentum score (higher = stronger momentum)

Field Notes

Sector concentration: Healthcare (5), Utilities (1)

Insider selling: BCRX (BioCryst Pharmaceuticals, Inc., -$1,818,506), PTGX (Protagonist Therapeutics, Inc., -$12,996,420), D (Dominion Energy, Inc., -$2,308,817)

Data coverage: 50.0% insider, 0.0% congressional, 0.0% earnings, 33.3% news

Peer Analysis

BEAM (Beam Therapeutics Inc.): Leads 5 peers: AGIO ($44.01), DNLI ($26.31), RXRX ($3.84), IBRX ($8.76), RCUS ($30.25)

TRVI (Trevi Therapeutics, Inc.): Leads 5 peers: ARDX ($5.38), WVE ($6.38), NVAX ($9.46), ZBIO ($27.68), UPB ($7.86)

PTGX (Protagonist Therapeutics, Inc.): Leads 5 peers: ALKS ($55.22), TGTX ($58.06), KYMR ($119.24), IMVT ($40.09), VKTX ($42.13)

BCRX (BioCryst Pharmaceuticals, Inc.): Leads 5 peers: ZYME ($26.72), ARDX ($5.38), MAZE ($32.84), PHVS ($34.59), SYRE ($94.23)

D (Dominion Energy, Inc.): Leads 5 peers: XEL ($80.67), EXC ($47.57), ETR ($115.19), PEG ($81.79), SRE ($94.59)

Recent Headlines

BCRX (BioCryst Pharmaceuticals, Inc.)

• BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTGX (Protagonist Therapeutics, Inc.)

• PTGX Stock Surges 64% in Six Months: What Is Driving the Rally?
• Protagonist Therapeutics Reports Granting of Inducement Awards

Vlad's Take

Today's signals: Strong sector concentration in Healthcare (5 signals) suggests sector-specific rotation. 3 signals showing insider selling warrant caution.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

📢 If you found this useful, a quick like, share, or subscribe keeps EverHint moving forward.